MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$32,739K
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
24,614
General and administrative
9,783
Total operating expenses
34,397
Operating loss
-34,397
Other income, net
1,659
Total other income, net
1,659
Loss before income tax expense
-32,738
Income tax expense
28
Net loss
-32,766
Unrealized gain on marketable securities
27
Comprehensive loss
-32,739
Basic EPS
-0.7
Basic Average Shares
46,980,777
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$32,739K Unrealized gain onmarketable securities$27K Net loss-$32,766K Other income, net$1,659K Loss before incometax expense-$32,738K Income tax expense$28K Total other income,net$1,659K Operating loss-$34,397K Total operatingexpenses$34,397K Research and development$24,614K General andadministrative$9,783K

DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Inc. (DMAC)